Contractor
MRIGLOBAL
- UEI
- HKQHNFKNKL15
- Parent UEI
- GW42LHLDZ418
- Resolved by
- uei
- Confidence
- 1.000
Active from Aug 31, 2021 to Aug 5, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 70RWMD23C00000023 MRIGLOBAL COST PLUS FIXED FEE DHS CWMD OBAA TOPIC SOLICITATION 15 AWARD FOR AGNOSTIC THREAT DETECTION SYSTEM (ATDS) PROPOSAL FOR RESEARCH AND DEVELOPMENT SERVICES | Department of Homeland Security | MO | Sep 27, 2023 | $4,594,443 |
| 75N98026D00014 NINDS DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) | Department of Health and Human Services | — | May 4, 2026 | — |
| 75N93021D00041 COMPREHENSIVE AND RAPID RESPONSE TO NIAID RESEARCH PROGRAMS | Department of Health and Human Services | — | Aug 31, 2021 | — |
| 75N91023D00010 IDIQ CONTRACT FOR CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT SERVICES | Department of Health and Human Services | — | Jun 29, 2023 | — |
| 75N93022D00002 EO14398 THE CONTRACTOR SHALL PROVIDE NIAID WITH A BROAD AND FLEXIBLE RANGE OF CAPABILITIES THAT ARE REQUIRED FOR PRECLINICAL AND TRANSLATIONAL DEVELOPMENT SUPPORT FOR PROMISING VACCINES AND RELATED PRODUCTS FOR HIV AND OTHER CANDIDATE AGENTS. | Department of Health and Human Services | — | Jul 23, 2026 | — |
| 75N93026F00001 REGULATORY SUPPORT FOR SOFTWARE AS MEDICAL DEVICE (SAMD) FOR NEXT-GEN SEQUENCING ID ANALYSIS | Department of Health and Human Services | MO | Mar 27, 2026 | $7,192 |
| 75N93024C00002 EO 14398; MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA) | Department of Health and Human Services | MD | Jul 20, 2026 | $5,169,142 |
| 75N91023D00007 EO 14398 ANALYSIS AND SYNTHESIS OF GMP AND NON-GMP BULK DRUGS AND PHARMACEUTICAL FORMULATIONS | Department of Health and Human Services | — | Jul 20, 2026 | — |
| 140D0425P0205 PER E.O 14398, THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO INCORPORATE FAR CLAUSE 52.222-90 ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS (DEVIATION APRIL 2026). | Department of the Interior | MD | Jul 20, 2026 | $739,894 |
| 75A50123F61001 BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES | Department of Health and Human Services | MO | Jul 17, 2026 | $149,664 |
| 75N98026F00001 PHASE 1 SINGLE ASCENDING DOSE PHARMACOKINETICS STUDY. ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT. JULY 20, 2026 - JANUARY 19, 2028. TASK ORDER 01. DAP-NCAP-00000009 | Department of Health and Human Services | MO | Jul 17, 2026 | $382,839 |
| 75N98026D00031 ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT. SINGLE AWARD R&D IDIQ CONTRACT. JULY 20, 2026 - JULY 19, 2031. DAP-NCAP-00000009 | Department of Health and Human Services | — | Jul 17, 2026 | — |
| 75N98026F00002 PHASE 1 SINGLE ASCENDING DOSE PHARMACOKINETICS STUDY: PARENT/METABOLITE(S). ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT. JULY 20, 2026 - JANUARY 19, 2028. TASK ORDER 02. DAP-NCAP-00000009 | Department of Health and Human Services | MO | Jul 17, 2026 | $478,052 |
| 68HERH25C0005 (PHILIS) PLATFORM MODERNIZATION: CHANGE ORDER PROPOSAL ACCEPTED AND INCORPORATED INTO THE CONTRACT, CEILING INCREASED BY $244,800.00,FUNDING OBLIGATED BY $244,800.00, AND THE PERIOD OF PERFORMANCE EXTENDED TO 01/17/27. | Environmental Protection Agency | NJ | May 20, 2026 | $13,813,179 |
| 75N95024D00012 EO 14398 IDIQ: CHEMISTRY, MANUFACTURING AND CONTROLS AND RELATED SERVICES FOR DEVELOPMENT OF DRUG SUBSTANCES | Department of Health and Human Services | — | Jul 15, 2026 | — |
| HHSN273201400020C CHEMISTRY RESEARCH SERVICES FOR THE DTT | Department of Health and Human Services | MO | Jun 25, 2026 | $52,417,033 |
| 47QRCA25DU229 ONE ACQUISITION SOLUTION FOR INTEGRATED SERVICES PLUS (OASIS+) UNRESTRICTED MULTIPLE AGENCY CONTRACT (MAC) | General Services Administration | — | Mar 27, 2026 | — |
| 75A50226C00001 PORTABLE BIOCONTAINMENT UNITS (PBCUS) - EBOLA RESPONSE 2026 | Department of Health and Human Services | MD | Jun 26, 2026 | $699,683 |
| 75N95019F00088 TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2020 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2025, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. | Department of Health and Human Services | MO | Jun 24, 2026 | $2,412,220 |
| 75N91023F00001 CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT | Department of Health and Human Services | MO | Jun 24, 2026 | $21,255,650 |
| HHSN27100001 TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2020 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2025, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. | Department of Health and Human Services | MO | Jun 24, 2026 | $514,881 |
| 75D30125D20639 DIAGNOSTIC TESTING IDIQ | Department of Health and Human Services | — | Sep 19, 2025 | — |
| 75N95022F00001 ML-246 (METARRESTIN) STABILITY STUDIES | Department of Health and Human Services | MO | Jun 3, 2026 | $131,900 |
| 75N93026F00003 PERFORMING FDA 510K ENABLING STUDIES FOR A DIAGNOSTIC TO DETECT CIPROFLOXICIN RESISTANCE OR SUSCEPTABILITY | Department of Health and Human Services | MO | May 11, 2026 | $1,571,051 |
| 75N91025F00001 MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE | Department of Health and Human Services | MO | Mar 5, 2026 | $3,460,074 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier HKQHNFKNKL15, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.